{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:57:00Z","timestamp":1740106620000,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.micpath.2019.04.028","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T17:09:16Z","timestamp":1555520956000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer"],"prefix":"10.1016","volume":"132","author":[{"given":"Mehdi","family":"Ajorloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Alamdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoorieh","family":"Soleimanjahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellah","family":"El Boulani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyad","family":"Khanizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi Razavi","family":"Nikoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.micpath.2019.04.028_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12026-009-8141-6","article-title":"Therapeutic hpv DNA vaccines","volume":"47","author":"Lin","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.micpath.2019.04.028_bib2","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.vaccine.2006.05.110","article-title":"Prophylactic HPV vaccines: underlying mechanisms","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.micpath.2019.04.028_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1470-2045(09)70227-X","article-title":"Development of therapeutic HPV vaccines","volume":"10","author":"Trimble","year":"2009","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.micpath.2019.04.028_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/138920209787581235","article-title":"Molecular signature of HPV-induced carcinogenesis: pRb, p53 and gene expression profiling","volume":"10","author":"Buitrago-Perez","year":"2009","journal-title":"Curr. Genom."},{"issue":"3","key":"10.1016\/j.micpath.2019.04.028_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.gt.3302646","article-title":"A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects","volume":"13","author":"Peng","year":"2006","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.micpath.2019.04.028_bib6","first-page":"75","article-title":"DNA vaccines for cervical cancer","volume":"2","author":"Huang","year":"2010","journal-title":"Am. J. Tourism Res."},{"issue":"11","key":"10.1016\/j.micpath.2019.04.028_bib7","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"15","key":"10.1016\/j.micpath.2019.04.028_bib8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/sj.gt.3302519","article-title":"Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope","volume":"12","author":"Huang","year":"2005","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.micpath.2019.04.028_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11373-006-9086-6","article-title":"A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity","volume":"13","author":"Lin","year":"2006","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.micpath.2019.04.028_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"issue":"19","key":"10.1016\/j.micpath.2019.04.028_bib11","doi-asserted-by":"crossref","first-page":"16391","DOI":"10.1074\/jbc.M200253200","article-title":"Accurate translation of the genetic code depends on tRNA modified nucleosides","volume":"277","author":"Yarian","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2019.04.028_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/viro.2002.1584","article-title":"Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity","volume":"301","author":"Liu","year":"2002","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.micpath.2019.04.028_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00262-002-0356-5","article-title":"IL-12: a promising adjuvant for cancer vaccination","volume":"52","author":"Portielje","year":"2003","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.micpath.2019.04.028_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"issue":"18","key":"10.1016\/j.micpath.2019.04.028_bib15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.gt.3301274","article-title":"IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice","volume":"7","author":"Song","year":"2000","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.micpath.2019.04.028_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00391826","article-title":"Estimation of liver tumor volume using different formulas\u2014an experimental study in rats","volume":"105","author":"Carlsson","year":"1983","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.micpath.2019.04.028_bib17","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1128\/IAI.73.9.5666-5674.2005","article-title":"Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B","volume":"73","author":"Ko","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.04.028_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.omtn.2017.07.011","article-title":"Codon-optimized P1A-encoding DNA vaccine: toward a therapeutic vaccination against P815 mastocytoma","volume":"8","author":"Lopes","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.micpath.2019.04.028_bib19","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/JVI.77.8.4928-4937.2003","article-title":"A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies","volume":"77","author":"Cid-Arregui","year":"2003","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2019.04.028_bib20","first-page":"180","article-title":"Antitumor response to a codon-optimized HPV-16 E7\/HSP70 fusion antigen DNA vaccine","volume":"14","author":"Soleimanjahi","year":"2017","journal-title":"Iranian J.Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2019.04.028_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/gt.2017.38","article-title":"Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation","volume":"24","author":"Sun","year":"2017","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.micpath.2019.04.028_bib22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1134\/S0026893315050064","article-title":"Antitumor effect of mIFN-\u03bb3 in C57BL\/6 mice model for papilloma tumors","volume":"49","author":"Choobin","year":"2015","journal-title":"Mol. Biol.."},{"issue":"11","key":"10.1016\/j.micpath.2019.04.028_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4161\/hv.21407","article-title":"IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques","volume":"8","author":"Jalah","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.micpath.2019.04.028_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.cgt.7700060","article-title":"Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response","volume":"6","author":"Tan","year":"1999","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.micpath.2019.04.028_bib25","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.175.11.7297","article-title":"A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors","volume":"175","author":"Berm\u00fadez-Humar\u00e1n","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2019.04.028_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAI.0000000000000830","article-title":"The safety and immunogenicity of an interleukin-12-enhanced multiantigen DNA vaccine delivered by electroporation for the treatment of HIV-1 infection","volume":"71","author":"Jacobson","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.micpath.2019.04.028_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121633","article-title":"Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7","volume":"10","author":"Lorenz","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.micpath.2019.04.028_bib28","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1038\/jid.2014.201","article-title":"IL-18, but not IL-12, induces production of IFN-gamma in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin","volume":"134","author":"Gosmann","year":"2014","journal-title":"J. Investig. Dermatol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018315961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018315961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T17:43:58Z","timestamp":1607276638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018315961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"alternative-id":["S0882401018315961"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.04.028","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}